LC
BSX icon

Luminist Capital’s Boston Scientific BSX Stock Holding History

Luminist Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.12K Buy
+120
New +$6.52K 0.01% 271
2026
Q1 		– Sell
-120
Closed -$11.4K – 119
2025
Q4 		$11.4K Hold
120
– – 0.01% 122
2025
Q3 		$11.5K Hold
120
– – 0.01% 168
2025
Q2 		$12.6K Buy
+120
New +$12.1K 0.01% 155

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Luminist Capital's BSX Position: Q2 2026 in Review

Luminist Capital opened a new position in Boston Scientific (BSX) in Q2 2026: 120 shares worth $5.12K. The stake represents 0.01% of the portfolio and ranks #271 among its holdings. This is a return to the name: Luminist Capital previously reported a position in BSX as recently as Q4 2025.

Luminist Capital first reported a position in BSX in Q2 2025 and has held it in 4 quarters since. The position peaked at $12.6K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Luminist Capital held 120 shares of Boston Scientific worth $5.12K as of Q2 2026.
  • Boston Scientific was a new Luminist Capital position in Q2 2026.
  • Boston Scientific made up 0.01% of Luminist Capital's portfolio in Q2 2026, its #271 holding.
  • Luminist Capital first reported a position in Boston Scientific in Q2 2025 and has held it in 4 quarters since.
  • Luminist Capital's Boston Scientific position peaked at $12.6K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Luminist Capital's 13F filing for Q2 2026, filed 7 Aug 2026.